Echocardiography and impedance cardiography as determinants of successful slow levosimendan infusion in advanced older heart failure patients
Gaetano Ruocco1
Guido Pastorini2
Mauro Feola2
1.Cardiology Unit,Riuniti of Valdichiana Hospital,USL-SUD-EST Toscana,Montepulciano,Siena,Italy2.Cardiology Unit,Regina Montis Regalis Hospital,ASL-CN1,Mondovì,Cuneo,Italy
摘要：Despite new therapeutic options, patients with heart failure (HF) still progress to advanced stage. In particular, patients who developed a severe left ventricular (LV) systolic and/or diastolic dysfunction with higher degree of NYHA class, recurrent hospitalizations for HF and showing a severe impairment of exercise capacity were defined as "advanced HF".[1] Levosimendan was recently approved in order to treat patients hospitalized for acute decompensated HF (ADHF) with severe systolic dysfunction. The pharmacological effects of levosimendan consists of inotropy, vasodilatation and cardioprotection increasing of calcium sensitivity.
机标关键词：advancedheartechoocarcardiographydeterminantsfailureimpedance
论文发表日期：2021-12-28
在线出版日期：2025-08-15（本平台首次上网日期，不代表文献的发表时间）
页数：5( 1058-1062 )